ANTI-CD19 CAR T CELL TRACKING PLATFORM FOR PRECLINICAL AND CLINICAL STUDIES SHOWS GREAT TUMOR BURDEN REDUCTION LINKED TO STEADY PERSISTENCE
LC Batista, H Brand, DMC Fantacini, DT Covas, LEB Souza
Centro de Terapia Celular (CTC), Fundação Hemocentro de Ribeirão Preto (FUNDHERP), Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, SP, Brazil
Read
1897
Timeswas read the article
883
Total PDF
1014
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 2 | 4 | 6 |
| 2025 5 | 40 | 20 | 60 |
| 2025 4 | 32 | 15 | 47 |
| 2025 3 | 39 | 12 | 51 |
| 2025 2 | 29 | 21 | 50 |
| 2025 1 | 28 | 22 | 50 |
| 2024 12 | 17 | 19 | 36 |
| 2024 11 | 20 | 21 | 41 |
| 2024 10 | 14 | 17 | 31 |
| 2024 9 | 23 | 25 | 48 |
| 2024 8 | 20 | 20 | 40 |
| 2024 7 | 20 | 22 | 42 |
| 2024 6 | 20 | 26 | 46 |
| 2024 5 | 31 | 25 | 56 |
| 2024 4 | 25 | 19 | 44 |
| 2024 3 | 31 | 16 | 47 |
| 2024 2 | 27 | 26 | 53 |
| 2024 1 | 25 | 17 | 42 |
| 2023 12 | 21 | 17 | 38 |
| 2023 11 | 39 | 33 | 72 |
| 2023 10 | 24 | 33 | 57 |
| 2023 9 | 32 | 27 | 59 |
| 2023 8 | 35 | 27 | 62 |
| 2023 7 | 30 | 9 | 39 |
| 2023 6 | 27 | 13 | 40 |
| 2023 5 | 44 | 17 | 61 |
| 2023 4 | 19 | 10 | 29 |
| 2023 3 | 21 | 14 | 35 |
| 2023 2 | 21 | 21 | 42 |
| 2023 1 | 15 | 6 | 21 |
| 2022 12 | 18 | 18 | 36 |
| 2022 11 | 20 | 25 | 45 |
| 2022 10 | 21 | 23 | 44 |
| 2022 9 | 21 | 23 | 44 |
| 2022 8 | 18 | 20 | 38 |
| 2022 7 | 20 | 25 | 45 |
| 2022 6 | 21 | 23 | 44 |
| 2022 5 | 14 | 24 | 38 |
| 2022 4 | 17 | 26 | 43 |
| 2022 3 | 21 | 18 | 39 |
| 2022 2 | 12 | 17 | 29 |
| 2022 1 | 11 | 13 | 24 |
| 2021 12 | 12 | 17 | 29 |
| 2021 11 | 13 | 21 | 34 |
| 2021 10 | 4 | 16 | 20 |
Show all
